Xiying Shao

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Combination Therapy

Protein Protein

Circulating Tumor

Top Venues

Molecular genetics & genomic medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jia-Yi Wu, Wei Wang, Lu Gao, Xiying Shao, Xiaojia Wang
Cyclin-dependent kinase inhibitors enhance programmed cell death protein 1 immune checkpoint blockade efficacy in triple-negative breast cancer by affecting the immune microenvironment. Cancer 130 (S8) (2024)
Jia-Yi Wu, Wei Wang, Lu Gao, Xiying Shao, Xiaojia Wang
Cyclin-dependent kinase inhibitors enhance programmed cell death protein 1 immune checkpoint blockade efficacy in triple-negative breast cancer by affecting the immune microenvironment. Cancer 130 (S8) (2024)
Jia-Yi Wu, Wei Wang, Lu Gao, Xiying Shao, Xiaojia Wang
Cyclin-dependent kinase inhibitors enhance programmed cell death protein 1 immune checkpoint blockade efficacy in triple-negative breast cancer by affecting the immune microenvironment. Cancer (2024)
Jia-Yi Wu, Wei Wang, Lu Gao, Xiying Shao, Xiaojia Wang
Cyclin-dependent kinase inhibitors enhance programmed cell death protein 1 immune checkpoint blockade efficacy in triple-negative breast cancer by affecting the immune microenvironment. Cancer 130 (S8) (2024)
Zhanhong Chen, Tian Sun, Zi-Yan Yang, Yabing Zheng, Ruoying Yu, Xue Wu, Junrong Yan, Yang W Shao, Xiying Shao, Wen-Ming Cao, Xiao-Jia Wang
Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA genomic profiling. Molecular genetics & genomic medicine 8 (2) (2019)